1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6121A5735DBCCA964002586F90015B342
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/SearchNew?OpenForm&Query=(clinical+and+trial)+and+(field+ItemCatalog=BMR)&SearchWV=1&sort=relevance&Start=1&Count=10&AQ=clinical+trial
18
19OpenForm&Query=(clinical+and+trial)+and+(field+ItemCatalog=BMR)&SearchWV=1&sort=relevance&Start=1&Count=10&AQ=clinical+trial
2035.170.64.36
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25BMR




Search Results

Results 1 - 10 of 293 Total Hits, Sorted by Relevance.

    |    

Best Practices for Managing Clinical Trials During and Beyond the COVID-19 PandemicDirect access to this research is not included with your membership level.

The COVID-19 pandemic has altered clinical trials timelines and protocols for many pharmaceutical companies, but technological advancements have enab... (ID CM-9)
Companies Profiled: Alcon, Alnylam Pharmaceuticals, Aptus Clinical, Atara Biotherapeutics, more ...

Clinical Affairs Excellence: Benchmarking Clinical Trial Strategies To Ensure Medical Device Success in a Global MarketplaceDirect access to this research is not included with your membership level.

In the face of cost and regulatory pressures, clinical programs at medical device organizations have looked to less expensive and regulated areas of the world to perform clinical trial activities... (ID POP-238)
Companies Profiled: Abbott Vascular, Medrad, Medtronic, Boston Scientific, more ...

Clinical Affairs Excellence: Benchmarking Clinical Trial Strategies for Pharmaceutical Success in a Global MarketplaceDirect access to this research is not included with your membership level.

In the face of cost and regulatory pressures, clinical programs at pharmaceutical organizations have looked to less expensive and regulated areas of the world to perform clinical trial activities... (ID POP-239)
Companies Profiled: Eisai, Abbott, Daiichi Sankyo, Merck Serono, more ...

Best Practices in Distributing Medical Info to Investigators and Physicians through Investigator Portals and Other MeansDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

Effective Medical Information groups must evaluate and prioritize how they disseminate critical information to a variety of key external stakeholders... (ID POP-329)
Companies Profiled: AbbVie, Allergan, Alnylam Pharmaceuticals, Boehringer Ingelheim, more ...

Managing Market Planning for New Oncology ProductsDirect access to this research is not included with your membership level.

Understand how leading pharmaceutical companies effectively manage market planning for oncology products during Phase II and Phase III... (ID PSM-205)

$628.00

Innovation in Combo Product Clinical Development – Harnessing Patient Insights from Reported Usability OutcomesDirect access to this research is not included with your membership level.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

As the healthcare industry gravitates toward increased patient centricity in an all-out effort to achieve the best possible health outcomes, it follo... (ID POP-308)
Companies Profiled: Novartis, Windtree Therapeutics, EMD Serono, Merck, more ...

Clinical Trial Excellence: Toolkit for Winning Investigators in a Competitive MarketplaceDirect access to this research is not included with your membership level.

Market competition is mounting to win the time, attention and interest of the most qualified clinical investigators... (ID OP-105)
Companies Profiled: ALTANA Pharmaceuticals, 3M Pharmaceuticals, Amersham Health, Amgen, more ...

Best Practices in the Oversight and Management of Investigator Initiated TrialsDirect access to this research is not included with your membership level.

The number of investigator-initiated trial (IIT) submissions in the healthcare industry has increased in recent years, marking them as a critical operational area for most biopharma manufacturers... (ID POP-327)
Companies Profiled: Alcon, Allergan, Arena Pharmaceuticals, Bayer, more ...

Addyi (flibanserin): How an upstart biopharma used social media and policy tools to support its NDA approval - and a $1 billion paydayDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

Developed in early 2000s for anxiety, flibanserin was repositioned for hyposexual desire disorder (HSDD) in the mid-2000s by Boehringer Ingelheim... (ID PSM-368)
Companies Profiled: Boehringer Ingelheim, Sprout Pharmaceuticals, Valeant

How Strong Medical Affairs Teams Use RWE to Achieve Impact along Patient, Disease State, Clinical and Payer FrontsDirect access to this research is not included with your membership level.

The demand for real world evidence (RWE) has skyrocketed among key stakeholders across the entire healthcare value chain: physicians, thought leaders... (ID POP-330)
Companies Profiled: Adamas Pharmaceuticals, ADC Therapeutics, Agios, Almirall, more ...